Has Pengbo Jiang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,629 in general payments to Pengbo Jiang, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pengbo Jiang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pengbo Jiang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pengbo Jiang, MD

Urology · Orange, CANPI 1699185603

Payments from drug & device makers

$12,629in general payments, 2019–2025

Across 51 payments — averaging $247.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$11K
Boston Scientific$1K
Calyxo, Inc.$335
KARL Storz Endoscopy-america$202

What the payments were for

Grants$1171%
Travel & lodging$2,62421%
Food & beverage$1,88815%
Education$8,00063%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	30	$10,917
Boston Scientific	15	$1,175
Calyxo, Inc.	3	$335
KARL Storz Endoscopy-america	3	$202

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,629 in reported general payments places this provider in the 75th percentile of 1,324 urology providers in California.

See all urology providers in California →

Medicare billing

Part B allowed, 2024

$154,818

Medicare patients

304

Services billed

907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Citrate ErPotassium Citrate	34	$2,547
Tamsulosin Hcl	133	$1,659
Finasteride	42	$501
Alfuzosin Hcl ErAlfuzosin Hcl	16	$420
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	32	$391
Oxybutynin Chloride ErOxybutynin Chloride	12	$253
Oxybutynin Chloride	30	$203
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	27	$135
Levofloxacin	29	$82

Paid to pharmacies, not to this prescriber.

Other urology in Orange

Edward UchioOrange$21.1M
Ralph ClaymanOrange$3.9M
Jaime LandmanOrange$851K
Faysal YafiOrange$346K
Stephen FreedlandWest Hollywood$16.7M
Alec KooTorrance$7.4M
Karim ChamieLos Angeles$4.3M
Siamak DaneshmandLos Angeles$3.5M
Arnold ChinLos Angeles$3.5M
Roger LiLoma Linda$2.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →